Dimethyl-1,2-oxazole-4-sulfonamide, 95+%, 250mg

FLEROXACIN, 95%, 1g

(S)-3-(((Benzyloxy)carbonyl)amino)butanoic acid, 95.0%, 1g

Methyl 4-chloro-3-methoxy-5-nitrobenzenecarboxylate, 95.0%, 250g

(S)-1-Aminoindane, 98.0%, 1g

n-Cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 98%, 5g

Au-Folie 99,9 % 0,05 x 50 x 50 mm 1 Stk

HALCINONIDE, 98%, 5g

(S)-(-)-2-Aminomethyl-1-ethylpyrrolidine>98.0%(GC)(T)5g

(S)-1-Amino-1-(4-fluorophenyl)-2-methylpropan-2-ol, 98%, 2g

tert-Butyl (2-(ethylamino)ethyl)carbamate, 95.0%, 25g

HPLC-Säule NUCLEODUR®, C8 Gravity, 5 µm, 250x4 mm, 1 Stück

2,3-Dibromonaphthalene>98.0%(GC)1g